Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 3
2004 7
2005 16
2006 18
2007 5
2008 18
2009 19
2010 13
2011 13
2012 15
2013 10
2014 20
2015 20
2016 20
2017 19
2018 27
2019 22
2020 21
2021 17
2022 19
2023 29
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
[Prostate cancer].
Sakamoto S, Ichikawa T. Sakamoto S, et al. Among authors: ichikawa t. Gan To Kagaku Ryoho. 2012 Jan;39(1):43-7. Gan To Kagaku Ryoho. 2012. PMID: 22454983 Review. Japanese. No abstract available.
This issue 30-8.
Ichikawa T. Ichikawa T. Int J Urol. 2023 Aug;30(8):623. doi: 10.1111/iju.15241. Int J Urol. 2023. PMID: 37527032 No abstract available.
This issue 30-2.
Ichikawa T. Ichikawa T. Int J Urol. 2023 Feb;30(2):127. doi: 10.1111/iju.15139. Int J Urol. 2023. PMID: 36763525 No abstract available.
Carbon-ion radiotherapy for urological cancers.
Ishikawa H, Hiroshima Y, Kanematsu N, Inaniwa T, Shirai T, Imai R, Suzuki H, Akakura K, Wakatsuki M, Ichikawa T, Tsuji H. Ishikawa H, et al. Among authors: ichikawa t. Int J Urol. 2022 Oct;29(10):1109-1119. doi: 10.1111/iju.14950. Epub 2022 Jun 12. Int J Urol. 2022. PMID: 35692124 Free PMC article. Review.
Epigenetic modifications in prostate cancer.
Sugiura M, Sato H, Kanesaka M, Imamura Y, Sakamoto S, Ichikawa T, Kaneda A. Sugiura M, et al. Among authors: ichikawa t. Int J Urol. 2021 Feb;28(2):140-149. doi: 10.1111/iju.14406. Epub 2020 Oct 27. Int J Urol. 2021. PMID: 33111429 Review.
This issue 31-3.
Ichikawa T. Ichikawa T. Int J Urol. 2024 Mar;31(3):193. doi: 10.1111/iju.15416. Int J Urol. 2024. PMID: 38461477 No abstract available.
323 results